Literature DB >> 2145321

Lack of induction of suppressor T cells by intestinal epithelial cells from patients with inflammatory bowel disease.

L Mayer1, D Eisenhardt.   

Abstract

The mechanisms underlying the chronic unrelenting inflammatory response seen in inflammatory bowel disease (IBD) are poorly understood. We have recently proposed a novel role for the normal intestinal enterocyte, that of antigen presenting cell. However, in contrast to conventional antigen presenting cells, normal enterocytes appear to selectively activate CD8+ antigen nonspecific suppressor T cells. To determine whether failure of this process may be occurring in inflammatory bowel disease, freshly isolated enterocytes from small and large bowel from normal patients, patients with Crohn's disease, ulcerative colitis, and inflammatory (diverticulitis, ischemic colitis, and gold induced colitis) controls were co-cultured with allogeneic T cells in a modified mixed lymphocyte reaction. In contrast to normal enterocytes, 42/42 Crohn's and 35/38 ulcerative colitis-derived epithelial cells stimulated CD4+ T cells, whereas 65/66 and 9/9 normal and inflammatory control enterocytes, respectively, stimulated CD8+ T cells (as previously described), suggesting that the results seen were not just a reflection of underlying inflammation. Furthermore, IBD enterocytes from both histologically involved and uninvolved tissue were similar in their ability to selectively activate CD4+ T cells, speaking for a more global defect in epithelial cells in IBD. Finally, activated T cells from IBD epithelial cell-stimulated mixed lymphocyte cultures displayed potent T helper activity in an antigen nonspecific fashion. Taken together, these data suggest that there may be an intrinsic defect in epithelial cells from patients with IBD, resulting in the inability to normally stimulate suppressor T cells in an antigen overloaded environment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2145321      PMCID: PMC296856          DOI: 10.1172/JCI114832

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  Virus isolation studies in Crohn's disease: a negative report.

Authors:  R J Phillpotts; J Hermon-Taylor; B N Brooke
Journal:  Gut       Date:  1979-12       Impact factor: 23.059

2.  Graft-versus-host disease induces expression of Ia antigen in rat epidermal cells and gut epithelium.

Authors:  D W Mason; M Dallman; A N Barclay
Journal:  Nature       Date:  1981 Sep 10-16       Impact factor: 49.962

3.  Human intestinal mononuclear cells. I. Investigation of antibody-dependent, lectin-induced, and spontaneous cell-mediated cytotoxic capabilities.

Authors:  R P MacDermott; G O Franklin; K M Jenkins; I J Kodner; G S Nash; I J Weinrieb
Journal:  Gastroenterology       Date:  1980-01       Impact factor: 22.682

4.  Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease.

Authors:  W S Selby; G Janossy; D Y Mason; D P Jewell
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

5.  Human colonic mononuclear cells: studies of cytotoxic function.

Authors:  Z M Falchuk; E Barnhard; I Machado
Journal:  Gut       Date:  1981-04       Impact factor: 23.059

6.  Human colonic intraepithelial and lamina proprial lymphocytes: cytotoxicity in vitro and the potential effects of the isolation method on their functional properties.

Authors:  M Chiba; W Bartnik; S G ReMine; W R Thayer; R G Shorter
Journal:  Gut       Date:  1981-03       Impact factor: 23.059

7.  Autologous mixed lymphocyte culture reactions and generation of cytotoxic T cells.

Authors:  R A Vande Stouwe; H G Kunkel; J P Halper; M E Weksler
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

8.  Human T cell hybridomas secreting factors for IgA-specific help, polyclonal B cell activation, and B cell proliferation.

Authors:  L Mayer; S M Fu; H G Kunkel
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

9.  In vitro studies of ulcerative colitis. I. Reactions of patients' serum with human fetal colon cells in tissue cultures.

Authors:  O BROBERGER; P PERLMANN
Journal:  J Exp Med       Date:  1963-05-01       Impact factor: 14.307

10.  Immunoregulatory T cell circuits in man. Alloantigen-primed inducer T cells activate alloantigen-specific suppressor T cells in the absence of the initial antigenic stimulus.

Authors:  N K Damle; E G Engleman
Journal:  J Exp Med       Date:  1983-07-01       Impact factor: 14.307

View more
  37 in total

Review 1.  Immunomodulation by thalidomide and thalidomide analogues.

Authors:  L G Corral; G Kaplan
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  Drug therapy of ulcerative colitis.

Authors:  B Crotty; D P Jewell
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

3.  Phenotypic characterization of isolated intraepithelial lymphocytes in patients with ulcerative colitis and normal controls.

Authors:  P Hoang; M Senju; J R Lowes; D P Jewell
Journal:  Dig Dis Sci       Date:  1992-11       Impact factor: 3.199

Review 4.  Immunopathogenesis of IBD: current state of the art.

Authors:  Heitor S P de Souza; Claudio Fiocchi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-12-02       Impact factor: 46.802

Review 5.  The epidemiology and risk factors of inflammatory bowel disease.

Authors:  Yulan Ye; Zhi Pang; Weichang Chen; Songwen Ju; Chunli Zhou
Journal:  Int J Clin Exp Med       Date:  2015-12-15

6.  Defective expression of gp180, a novel CD8 ligand on intestinal epithelial cells, in inflammatory bowel disease.

Authors:  L S Toy; X Y Yio; A Lin; S Honig; L Mayer
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

7.  Characterisation and quantification of mucosal cytokine that induces epithelial histocompatibility locus antigen-DR expression in inflammatory bowel disease.

Authors:  J R Lowes; P Radwan; J D Priddle; D P Jewell
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

8.  Adaptive immune responses during Shigella dysenteriae type 1 infection: an in vitro stimulation with 57 kDa major antigenic OMP in the presence of anti-CD3 antibody.

Authors:  Ashim Kumar Bagchi; Ajoy Kumar Sinha; Rushita Adhikari; Joydeep Mukherjee
Journal:  Mol Cell Biochem       Date:  2009-11-14       Impact factor: 3.396

9.  Histological and immunological features of appendix in patients with ulcerative colitis.

Authors:  Yukihiko Jo; Takayuki Matsumoto; Shinichiro Yada; Shotaro Nakamura; Takashi Yao; Masayuki Hotokezaka; Ryuichi Mibu; Mitsuo Iida
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

10.  Human colonic intraepithelial lymphocytes from patients with inflammatory bowel disease fail to down-regulate proliferative responses of primed allogeneic peripheral blood mononuclear cells after rechallenge with antigens.

Authors:  H R Dalton; M C Dipaolo; G K Sachdev; B Crotty; P Hoang; D P Jewell
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.